TV personality Tyler Henry shares health update post brain tumor surgery
He said that he is "doing much better" one month after doctors successfully removed a non-cancerous, fluid-filled cyst near the centre of his brain.
Tyler Henry is a reality show personality who appears in the reality show series Hollywood Medium with Tyler Henry and Life After Death with Tyler Henry.
"I'm very lucky," said Tyler in an interview. "I was dealing with something called hydrocephalus, which is basically fluid being stuck around the brain and causing inflammation."
He noted that his tumour had an "incidence rate of one in 3 million,"adding, "I should play the lottery."
Tyler has been "amazed" by his quick recovery. Within weeks of his operation, he was already performing readings as part of his "An Evening of Hope and Healing" series of live shows, as reported by the outlet.
"I was worried with anything related to the brain that it might affect my ability,"he shared, adding, "but I found that not having brain inflammation actually made things a lot clearer."
Tyler said he was "dealing with a lot of confusing symptoms, just kind of hard to orient physically," reported E! News.
"I would sometimes feel kind of slow in responses and deal with aphasia," he recounted, "where I couldn't really find my words."
However, this was not the first time Tyler had struggled with psychological symptoms. He already dealt with an arachnoid cyst, a benign mass situated on the arachnoid membrane, a protective layer surrounding the brain and spinal cord, during his teenage years.
"I had been diagnosed previously with some form of a mass in the back of my brain," he shared. "When I was 18, I underwent brain surgery--then endoscopically--and it took about 10 years for it come back after it resealed. So, it was nothing new necessarily," reported E! News. (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
4 hours ago
- News18
Two-day national conclave FITT Forward 2025 begins tomorrow at IIT Delhi
New Delhi [India], August 20 (ANI): As India moves towards a transformative decade of deep-tech innovations, FITT Forward 2025 (21-22 August 2025, FITT-IIT Delhi campus) is being held at a decisive was organized by the Foundation for Innovation and Technology Transfer (FITT) at IIT Delhi. This two-day national conclave is bringing together deep-tech startups, policymakers, global investors, and research leaders on one platform to further place India on the global innovation map, the release said. Under the guidance of Dr. Nikhil Agarwal, Managing Director, FITT; Prof. Preeti Ranjan Panda, Dean (Corporate Relations); and Prof. Rangan Banerjee, Director, IIT Delhi, FITT Forward 2025 will see innovators, investors, and industry leaders come together to accelerate major changes in India's deep-tech sector. Through collective efforts, emerging ideas will be transformed into practical, scalable conference is set to define the next phase of India's startup journey, aligning with national initiatives such as Startup India, Make in India, and Atmanirbhar two-day platform will see participation from several senior government officials, over 30 early-stage and scaling startups from across the country, investors, and more. During the event, over 20 MoUs, more than 30 startup-investor meetings, and 8-10 CSR partnership announcements are anticipated, a release are several startups making debut in India which will be showcased here;– A cutting-edge bio-processing technology developed in collaboration with IIT Delhi that transforms ordinary fabrics into skin-friendly, herbal wellness garments.– A healthcare innovator launching a portable diagnostic device that can detect proteins in urine, bringing affordable, lab-grade testing to rural areas where economic constraints prevent people from accessing such facilities. – Another startup developing medical simulators for neurosurgery, including brain ventriculostomy and shunt placement, for use in training hospitals across the country.– An innovation bringing a transdermal delivery platform for multi-micronutrients, replacing pills with smart patches that the body absorbs more efficiently.– A healthcare platform that collects real-time data from wearables and alerts users to serious health anomalies even before symptoms appear. – Another startup has built a range of period-care and feminine hygiene products using organic, chemical-free, and skin-safe ingredients.– A new-age fabric will be launched that destroys 99.9% of bacteria and viruses within 30 minutes.– Additionally, India's first robot for swimming pool cleaning and disinfection, already awarded as the best robotics startup, is now ready for public launch. (ANI)
News18
4 hours ago
- News18
Worlds first human spinal cord implant to take place in Israel
Tel Aviv [Israel], August 20 (ANI/TPS): Israel is preparing to perform the world's first-ever human spinal cord implant using a patient's own cells, a medical breakthrough that could allow paralysed patients to stand and walk again, Tel Aviv University announced on surgery, expected in the coming months, will take place in Israel and marks a historic milestone in regenerative to the World Health Organisation, over 15 million people worldwide are living with spinal cord injuries, with the majority resulting from traumatic causes such as falls, road traffic accidents, and spinal cord injuries cannot be fully cured, so treatment focuses on stabilising the patient, preventing further damage, and maximising function. Emergency care often involves immobilising the spine, reducing inflammation, and sometimes performing surgery to repair fractures or relieve pressure. Rehabilitation includes physical and occupational therapy, as well as assistive devices like wheelchairs and braces. While experimental therapies–including stem cells and robotic devices–are being explored, no treatment yet reliably restores full spinal cord cord injuries are one of the few human injuries where the body cannot naturally heal itself, and the tissue is both structurally complex and extremely sensitive.'The spinal cord transmits electrical signals from the brain to all parts of the body. When it is severed by trauma such as a car accident, a fall, or a combat injury, the chain is broken. Think of an electrical cable that has been cut: when the two ends no longer touch, the signal cannot pass, and the patient remains paralysed below the injury," explained Professor Tal Dvir, head of the Sagol Centre for Regenerative Biotechnology and the Nanotechnology Centre at Tel Aviv University, who is leading the effort. Dvir is also the chief scientist at Matricelf, the Israeli biotech company commercialising the other tissues, spinal cord neurons cannot naturally regenerate, and over time, scar tissue blocks remaining signals. The new procedure aims to replace the damaged section with a lab-grown spinal cord that fuses with healthy tissue above and below the injury. Animal studies in rats have shown remarkable results, with the animals regaining the ability to walk innovation began about three years ago, when Dvir's lab engineered a personalised three-dimensional human spinal cord in the laboratory. The findings, published in the peer-reviewed journal Advanced Science, showed that mice with chronic paralysis regained mobility after receiving the engineered procedure begins with blood cells from the patient, which are reprogrammed into stem-cell-like cells capable of becoming any cell type. Fat tissue is also collected to create a custom hydrogel scaffold, into which the stem-like cells develop into a spinal cord structure. This engineered tissue is then implanted, replacing scarred areas and reconnecting the nervous system.A few months ago, Prof. Dvir and his team received preliminary approval from Israel's Ministry of Health for 'compassionate use" trials in eight patients, making Israel the first country to attempt this procedure. 'This is undoubtedly a matter of national pride. The technology was developed here in Israel, at Tel Aviv University and at Matricelf, and from the very beginning it was clear to us that the first-ever surgery would be performed in Israel, with an Israeli patient," Dvir technology was then commercialised through Matricelf, which was founded in 2019 under a licensing agreement with Tel Aviv University's technology transfer company, Ramot.'This milestone marks the shift from pioneering research to patient treatment. Using each patient's own cells eliminates key safety risks and positions Matricelf at the forefront of regenerative medicine. This first procedure is more than a scientific breakthrough; it is a step toward transforming an area of medicine long considered untreatable," said Matricelf CEO Gil added, 'If successful, this therapy could define a new standard of care in spinal cord repair, addressing a multi-billion-dollar market with no effective solutions today. We are proud that Israel is leading this global effort and are fully committed to bringing this innovation to patients worldwide."'Our goal is to help paralysed patients rise from their wheelchairs. The animal model trials showed extraordinary success, and we are hopeful that the results in humans will be just as promising," Dvir said. (ANI/TPS)
News18
8 hours ago
- News18
India dispatches 32 tonnes of humanitarian assistance to Peru: MEA
New Delhi [India], August 20 (ANI): India on Wednesday dispatched 32 tonnes of humanitarian assistance to Peru, including 250,000 units of physiological saline solution, which will support patients suffering from dehydration in the South American country..
